Literature DB >> 8843085

Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex.

R Schmidt-Kastner1, C Wetmore, L Olson.   

Abstract

Brain-derived neurotrophic factor (BDNF) is important for the development and trophic support of several neuronal groups in the rat. In the present study, the distribution of BDNF messenger RNA was studied by in situ hybridization, and the cellular localization of BDNF protein was investigated with anti-peptide antibodies. Anatomical investigations were also made in animals with prolonged epileptic seizures which show an enhanced expression of BDNF messenger RNA. Major forebrain areas studied were the hippocampus, striatum and cortex. The messenger RNA coding for the putative high-affinity receptor, tyrosine kinase B, was also visualized using in situ hybridization with a probe specific for the full-length form. In the hippocampus, granule cells and pyramidal neurons expressed BDNF messenger RNA and BDNF-like immunoreactivity. Interneurons in dendritic layers did not show labelling with either method. Tyrosine kinase B messenger RNA was found within neurons in all these regions. In the medial septum-diagonal band, nucleus basalis and lateral hypothalamus, neurons with punctate cytoplasmic immunofluorescence were found, and neurons in the lateral septum were diffusely positive for BDNF. In striatum, positive labelling of medium-sized neurons was found with the antibody, whereas BDNF messenger RNA was only detectable during seizures. A laminar pattern of neuronal labelling for BDNF messenger RNA and protein was found in the neocortex. The analysis of the anatomical distribution of BDNF-producing cells suggests a number of possible cellular interactions. In the hippocampus, BDNF might act in an autocrine or paracrine manner for granule cells and pyramidal neurons, and, in addition, may serve as a signal from these principal cells to interneurons. BDNF could be a target-derived and a locally produced trophic factor for cholinergic neurons in the medial septum. The expression of BDNF in the striatum suggests that this factor could be a target-derived factor for dopaminergic neurons of substantia nigra and/or work as an autocrine/ paracrine factor within the striatum itself.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843085     DOI: 10.1016/0306-4522(96)00093-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons.

Authors:  E Tongiorgi; M Righi; A Cattaneo
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

2.  Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures.

Authors:  M M Bolton; A J Pittman; D C Lo
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

3.  Genetic Increases in Olfactory Bulb BDNF Do Not Enhance Survival of Adult-Born Granule Cells.

Authors:  Brittnee McDole; Rachel Berger; Kathleen Guthrie
Journal:  Chem Senses       Date:  2020-01-01       Impact factor: 3.160

4.  Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain.

Authors:  Suzanne Numan; Christine M Gall; Kim B Seroogy
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.

Authors:  Kirk I Erickson; Ruchika Shaurya Prakash; Michelle W Voss; Laura Chaddock; Susie Heo; Molly McLaren; Brandt D Pence; Stephen A Martin; Victoria J Vieira; Jeffrey A Woods; Edward McAuley; Arthur F Kramer
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

6.  Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

Authors:  B A Horger; C A Iyasere; M T Berhow; C J Messer; E J Nestler; J R Taylor
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  Piperine-like alkamides from Piper nigrum induce BDNF promoter and promote neurite outgrowth in Neuro-2a cells.

Authors:  Young Sook Yun; Sachie Noda; Shigeru Takahashi; Yuji Takahashi; Hideshi Inoue
Journal:  J Nat Med       Date:  2017-10-23       Impact factor: 2.343

8.  Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats.

Authors:  Giovanni Vitale; Valentina Ruggieri; Monica Filaferro; Claudio Frigeri; Silvia Alboni; Fabio Tascedda; Nicoletta Brunello; Remo Guerrini; Carlo Cifani; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2009-08-27       Impact factor: 4.530

Review 9.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

10.  Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation.

Authors:  Christopher G Vecsey; Joshua D Hawk; K Matthew Lattal; Joel M Stein; Sara A Fabian; Michelle A Attner; Sara M Cabrera; Conor B McDonough; Paul K Brindle; Ted Abel; Marcelo A Wood
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.